- CVS Health will split into two independent companies, separating its pharmacy business from its insurance business.
- OVINTIV INC. <OVV.N>: MIZUHO RAISES TARGET PRICE TO $82 FROM $75
- LivaNova raises 2026 constant-currency revenue growth forecast to 9%-10%
- DUOLINGO, INC. <DUOL.O>: D.A. DAVIDSON RAISES TARGET PRICE TO $180 FROM $175
- ONEOK, INC. <OKE.N>: MIZUHO RAISES TARGET PRICE TO $101 FROM $95
- Bank JTrust Indonesia Plans to Appoint Abdullah Firman Wibowo as President Director
- ONE GAS, INC. <OGS.N>: MIZUHO RAISES TARGET PRICE TO $90 FROM $89
- LABCORP <LH.N>: MIZUHO RAISES TARGET PRICE TO $400 FROM $355
- AdvanSix 3Q 2026 net loss more than doubles to $7.56 million
- INTERNATIONAL FLAVORS & FRAGRANCES INC. <IFF.N>: MIZUHO RAISES TARGET PRICE TO $102 FROM $92
- Aeries Technology Updates Financial Calendar
- Cencora Sees FY27 Capital Spending About $1B >COR
- Cencora Sees FY27 Adjusted Free Cash Flow About $3.5B >COR
- Cencora Sees FY27 Adjusted Operating Income Up 4%-6% >COR
- DUPONT <DD.N>: MIZUHO RAISES TARGET PRICE TO $165 FROM $156
- TBS Energi Utama Says Investors Commit Up to SGD 555 Million to Fund Waste Management Expansion
- COUPANG, INC. <CPNG.N>: MIZUHO CUTS TARGET PRICE TO $21 FROM $22
- Cencora Consolidates Specialty Businesses Under Single Leader
- EQUITABLE HOLDINGS, INC. <EQH.N>: MIZUHO RAISES TARGET PRICE TO $67 FROM $66
- CARMAX INC <KMX.N>: MIZUHO RAISES TARGET PRICE TO $50 FROM $43
- BOOKING HOLDINGS INC. <BKNG.O>: MIZUHO CUTS TARGET PRICE TO $205 FROM $240
- Zimmer Biomet Q3 diluted EPS falls 14% to $1; Q3 net sales rise to $2.06 billion
- Ralliant Q3 2026 net earnings more than double year over year to $86.1 million
- BALL CORP <BALL.N>: MIZUHO RAISES TARGET PRICE TO $75 FROM $72
- Westlake Expects Fourth-Quarter HIP Revenue of $900 Million to $1 Billion
- AXSOME THERAPEUTICS, INC. : MIZUHO CUTS TARGET PRICE TO $272 FROM $284
- CVS Health plans to separate into two publicly traded companies by first half of 2028
- BRIEF-Cencora Q4 Adjusted EPS USD 4.66 Vs. IBES Estimate USD 4.58
- Versigent Q3 2026 attributable net income falls 6% to $102 million; Q3 2026 net sales rise 7% to $2.45 billion
- Perrigo Swings to Q3 Net Loss of $27.5 Million
- TPG Mortgage Investment Trust posts Q3 net loss available to common stockholders of $0.49 per diluted share
- Radisson Mining drilling extends gold mineralization at O'Brien project
- Freshpet management commentary attributes Q3 2026 adjusted gross margin improvement to stronger operating performance
- United Therapeutics Q3 Net Income Falls 24% to $258.6 Million
- ESAB Q3 net income drops 29% to $40.28 million
- Hannan Metals completes second drill program at Stavaträsk gold project in Sweden
- BioMérieux Publishes Q3 2026 Results Call Transcript
- Westlake Q3 2026 swings to net profit of $6 million from year-earlier loss
- Eagle Materials Q2 FY27 net earnings fall 19% to $111.53 million
- WEG Buys Land in India for US$ 8 Million to Expand Operations
- Adtraction corrects interim report to include omitted January-September 2025 changes in equity
- Vermilion Energy Q3 turns to net loss of CAD 34.64 million
- Bluejay Diagnostics Announces 1-for-4 Reverse Stock Split Effective November 3
- BOOKING HOLDINGS INC. <BKNG.O>: WELLS FARGO CUTS TARGET PRICE TO $179 FROM $190
- CINEMARK HOLDINGS, INC. <CNK.N>: WELLS FARGO RAISES TARGET PRICE TO $42 FROM $34
- Westlake Chemical Partners Q3 2026 attributable net income rises 11% year over year to $16.22 million
- Hut 8 3Q Rev $71.1M >HUT
- FORTUNE BRANDS INNOVATIONS, INC. <FBIN.N>: WELLS FARGO RAISES TARGET PRICE TO $51 FROM $48
- UL SOLUTIONS INC. <ULS.N>: WELLS FARGO RAISES TARGET PRICE TO $105 FROM $104
- ULTRAGENYX PHARMACEUTICAL INC. <RARE.O>: WELLS FARGO RAISES TARGET PRICE TO $19 FROM $18
- RXSIGHT, INC. <RXST.O>: WELLS FARGO CUTS TARGET PRICE TO $6 FROM $9
- Zimmer Biomet Holdings Narrows 2026 Revenue Growth View to 4.4%-4.9% From 3.9%-4.9% >ZBH
- FTC Solar 3Q Rev $32.8M >FTCI
- FTC Solar 3Q Loss/Shr 54c >FTCI
- TPG Mortgage Invst Trust Had $9.27 Book Value Per Shr as of Sept 30 >MITT
- NURIX THERAPEUTICS, INC. <NRIX.O>: WELLS FARGO CUTS TARGET PRICE TO $20 FROM $25
- NUVEEN CHURCHILL DIRECT LENDING CORP. <NCDL.N>: WELLS FARGO CUTS TARGET PRICE TO $11 FROM $12
- AMGEN INC. : WELLS FARGO RAISES TARGET PRICE TO $460 FROM $430
- AMERICAN WELL CORPORATION : WELLS FARGO RAISES TARGET PRICE TO $18 FROM $16
- SUNOCO LP <SUN.N>: WELLS FARGO RAISES TARGET PRICE TO $85 FROM $82
- DIAMONDBACK ENERGY, INC. <FANG.O>: WELLS FARGO CUTS TARGET PRICE TO $244 FROM $263
- MARATHON PETROLEUM CORPORATION <MPC.N>: WELLS FARGO RAISES TARGET PRICE TO $564 FROM $560
- HESS MIDSTREAM LP <HESM.N>: WELLS FARGO CUTS TARGET PRICE TO $34 FROM $40
- ONEMAIN HOLDINGS, INC. <OMF.N>: WELLS FARGO CUTS TARGET PRICE TO $62 FROM $65
- PENNYMAC MORTGAGE INVESTMENT TRUST : WELLS FARGO CUTS TARGET PRICE TO $9 FROM $10
- REDWOOD TRUST, INC. <RWT.N>: WELLS FARGO CUTS TARGET PRICE TO $3.5 FROM $6
- NEW MOUNTAIN FINANCE CORP. <NMFC.O>: WELLS FARGO CUTS TARGET PRICE TO $7 FROM $7.5
- Kennametal Sees FY Adj EPS $5-Adj EPS $6 >KMT
- Kennametal Sees FY Sales $3.33B-$3.45B >KMT
- Ralliant 3Q EPS 77c >RAL
- Ralliant 3Q Sales $620.1M >RAL
- Kennametal Sees 2Q Adj EPS $1.20-Adj EPS $1.50 >KMT
- Westlake 3Q Sales $2.98B >WLK
- Eagle Materials 2Q Rev $652.7M >EXP
- Zimmer Biomet Holdings 3Q Adj EPS $1.90 >ZBH
- Zimmer Biomet Holdings 3Q Net $191.6M >ZBH
- Freshpet 3Q Sales $317.8M >FRPT
- ESAB 3Q Sales $825M >ESAB
- ESAB 3Q Cont Ops EPS 61c >ESAB
- United Therapeutics 3Q Rev $832.5M >UTHR
- -- Earnings Flash (UTHR) United Therapeutics Posts Q3 EPS $5.71, vs. FactSet Est of $6.01
- --Earnings Flash (EXP) Eagle Materials Posts Fiscal Q2 EPS $3.63, vs. FactSet Est of $3.76
- UBS Adjusts Price Target on Amgen to $530 From $470
- --Earnings Flash (FRPT) Freshpet Posts Q3 EPS $0.58, vs. FactSet Est. of $0.39
- -- Earnings Flash (KMT) Kennametal Posts Fiscal Q1 EPS $3.48, vs. FactSet Est of $2.66
- -- Earnings Flash (WLKP) Westlake Chemical Partners LP Reports Q3 Revenue $314.5M, vs. FactSet Est of $336.3M
- -- Earnings Flash (FRPT) Freshpet, Inc. Reports Q3 Revenue $317.8M, vs. FactSet Est of $312.0M
- NCR Atleos Q3 Adjusted Earnings Rise, Revenue Falls
- Clear Secure Q3 Earnings, Revenue Increase; Q4 Guidance Issued; Share Buyback Program Increased
- -- Earnings Flash (VGNT) Versigent PLC Posts Q3 Adjusted EPS $1.91 per Share, vs. FactSet Est of $1.83
- Suncor Energy Q3 Adjusted Operating Earnings Rise YoY
- -- Earnings Flash (PRGO) Perrigo Reports Q3 Revenue $988.6M, vs. FactSet Est of $984.8M
- -- Earnings Flash (VGNT) Versigent PLC Reports Q3 Revenue $2.45B, vs. FactSet Est of $2.42B
- -- Earnings Flash (COR) Cencora Reports Q4 Revenue $88.35B, vs. FactSet Est of $87.95B
- -- GUIDANCE: (KMT) Kennametal Inc. Expects Q2 Revenue Range $785.0M - $815.0M
- --Earnings Flash (WLK) Westlake Posts Q3 Sales $2.98B, vs. FactSet Est of $2.94B
- -- GUIDANCE: (KMT) Kennametal Inc. Expects Q2 Adjusted EPS Range $1.20 - $1.50
- -- Earnings Flash (KMT) Kennametal Inc. Reports Q1 Revenue $768.2M, vs. FactSet Est of $770.4M
- -- Earnings Flash (COR) Cencora Posts Q4 Adjusted EPS $4.66 per Share, vs. FactSet Est of $4.58
- --Earnings Flash (WLK) Westlake Posts Q3 Adjusted EPS $0.45, vs. FactSet Est of $0.49
